DAMASK, AMY,LEWITZKY, STEVEN,ROTTE, MICHAEL ANDREAS
申请号：
CA2943326
公开号：
CA2943326A1
申请日:
2015.04.08
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The disclosure is directed to novel predictive methods and personalized therapies for treating asthma. Specifically, this disclosure relates to methods of treating a patient having asthma by selectively administering an IL-13 antagonist, on the basis of that patient being genetically predisposed to have a favorable response to treatment with the IL-13 antagonist. Also disclosed herein are transmittable forms of information, diagnostic methods, and kits useful in predicting the likelihood that a patient having asthma will respond to treatment with an IL-13 antagonist.
